Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

´ãÁó»ê ÇÕ¼ºÀ¯µµÃ¼(HS-1200)°¡ ÀÎü À¯¹æ¾Ï ¼¼Æ÷ÁÖ(MCF-7)¿¡¼­ À¯µµÇÏ´Â ¹æ»ç¼± °¨ÀÛ È¿°ú A Novel Chenodeoxycholic Derivative HS-1200 Enhances Radiation-induced Apoptosis in Human MCF-7 Breast Cancer Cells

´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö 2004³â 22±Ç 2È£ p.145 ~ 154
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÇü½Ä/Lee HS ÃÖ¿µ¹Î/±ÇÇõÂù/¼Û¿¬¼÷

Abstract

¸ñ Àû: ÀÎü À¯¹æ¾Ï ¼¼Æ÷ÁÖÀÎ MCF-7¿¡ »õ·Î¿î CDCA ÇÕ¼ºÀ¯µµÃ¼ÀÎ HS-1200À» ¹æ»ç¼±°ú ÇÔ²² óġÇÏ¿© ¾ÆÆ÷Åä½Ã½º À¯µµ È°¼º ¹× ¹æ»ç¼± °¨ÀÛ È¿°ú¸¦ °üÂûÇÏ°íÀÚ ÇÏ¿´´Ù.

´ë»ó ¹× ¹æ¹ý: MCF-7 ¼¼Æ÷¿¡ 2¢¦8 GyÀÇ X-ray¿Í 16¥ìM ³óµµÀÇ HS-1200À» ó¸®ÇÑ ¼¼Æ÷µéÀÇ ¼¼Æ÷ »ýÁ¸ °î¼±À» clonogenic assay¸¦ ÅëÇÏ¿© ±¸ÇÏ¿´´Ù. ¾ÆÆ÷Åä½Ã½º À¯µµ È®ÀÎÀº 8 GyÀÇ X-ray¿Í 40¥ìM ³óµµÀÇ HS-1200À» Àü óġÇÏ¿© ±¸ÇÑ agarose gel Àü±â¿µµ¿ ¹× Hoechst stainingÀ» ÀÌ¿ëÇÏ¿´´Ù. ¸é¿ªÇü±¤¹ýÀ» ÀÌ¿ëÇÑ cytochrome c, Bax ¹× AIF µéÀÇ °üÂû°ú ¹ÌÅäÄܵ帮¾Æ ¸·ÀüÀ§ ÃøÁ¤À» ½ÃÇàÇÏ¿´´Ù. Western blottingÀ» ÅëÇÑ PARP (poly (ADP-ribose) polymerase) cleavage, Bax, Bcl-2, Bak ¹× AIF µéÀÇ ¹ßÇöÀ» °üÂûÇÏ¿´´Ù.

°á °ú: 2¢¦8 GyÀÇ X-ray¸¦ Á¶»çÇÑ ±º(R)°ú HS-1200 ó¸® ÈÄ 2¢¦8 GyÀÇ X-ray¸¦ Á¶»ç ÇÑ ±º(HR)ÀÇ ¼¼Æ÷ »ýÁ¸ °î¼±À» ºñ±³ÇÏ´Ï HR ±º¿¡¼­ ¼¼Æ÷ °¨ÀÛ È¿°ú¸¦ °üÂûÇÒ ¼ö ÀÖ¾ú´Ù. DNA ladder´Â R±º¿¡¼­´Â 72 ½Ã°£Â° °üÂûµÇ´Â ¹Ý¸é¿¡ HR ±º¿¡¼­´Â 24½Ã°£Â° °üÂûµÇ¾î DNA ºÐÀýÀÌ ºü¸£°Ô ÁøÇàµÊÀ» ¾Ë ¼ö ÀÖ¾ú°í, PARP cleavageÀÇ °üÂû¿¡¼­µµ R ±º¿¡ ºñÇØ 24½Ã°£ ºü¸£°Ô ÁøÇàµÇ¾ú´Ù. ¸é¿ª Çü±¤¹ýÀ» ÀÌ¿ëÇÑ ½ÇÇè¿¡¼­µµ HR ±ºÀÌ R ±º¿¡ ºñÇÏ¿© ¹ÌÅäÄܵ帮¾Æ ¸·ÀüÀ§(¥Ä¥×m)ÀÇ ±Þ°ÝÇÑ °¨¼Ò, cytochromeÀÇ ´Ù·® ¹æÃâ, BaxÀÇ Áõ°¡µÈ Á¡»ó º¯È­ µîÀÌ °üÂûµÇ¾ú°í, AIFÀÇ º¯È­´Â ¶Ñ·ÇÇÏÁö ¾Ê¾Ò´Ù. Western blottingÀ» ÀÌ¿ëÇÑ Bax, Bcl-2, Bak ¹× AIFµéÀÇ ¹ßÇöÀ» °üÂûÇÏ¿´À» ¶§ Bax ¸¸ HR ±º¿¡¼­ ½Ã°£´ëº°·Î Áõ°¡µÇ´Â Ãß¼¼¸¦ º¸ÀÎ ¹Ý¸é Bcl-2, Bak ¹× AIFµéÀÇ ¹ßÇöÀº ƯÀÌÇÑ Â÷À̸¦ ¹ß°ßÇÒ ¼ö ¾ø¾ú´Ù.

°á ·Ð: ÀÎü À¯¹æ¾Ï ¼¼Æ÷ÁÖ(MCF-7)¿¡¼­ »õ·Î¿î ´ãÁó»ê ÇÕ¼º À¯µµÃ¼ÀÎ HS-1200Àº ¹æ»ç¼± Á¶»ç¿¡ ÀÇÇÑ ¾ÆÆ÷Åä½Ã½ºÀÇ À¯µµ¸¦ °¨ÀÛ½ÃÅ°´Â »ç½ÇÀ» °üÂûÇÏ¿´´Ù. ¾ÆÆ÷Åä½Ã½º À¯µµ°¨ÀÛ Áõ°¡´Â Bax/Bcl-2 ºÐÀ²ÀÇ »ó´ëÀû Áõ°¡·Î ±âÀÎÇÑ´Ù°í »ý°¢ÇÑ´Ù. »ó±â °á°ú¸¦ Åä´ë·Î HS-1200ÀÇ Ç×¾Ï Ä¡·áÁ¦·Î¼­ÀÇ ¿ªÇÒ¿¡ °üÇÑ ±âÃÊ ÀÚ·á·Î¼­ÀÇ À¯¿ë¼ºÀ» Á¦½ÃÇÒ ¼ö ÀÖ¾ú´Ù.

Purpose: To examine whether a synthetic bile acid derivatives (HS-1200) sensitizes the radiation-induced apoptosis in human breast cancer cells (MCF-7) and to investigate the underlying mechanism.

Materials and Methods: Human breast cancer cells (MCF-7) in exponential growth phase were treated with HS-1200 for 24 hours at 37oC with 5% CO2 in air atmosphere. After removal of HS-1200, cells were irradiated with 2¢¦8 Gy X-ray, and then cultured in drug-free media for 24-96 hours. The effect of radiation on the clonogenicity of MCF-7 cells was determined with clonogenic cell survival assay with 16¥ìM of HS-1200. The induction of apoptosis was determined using agarose gel electrophoresis and Hoechst staining. The expression level of apoptosis-related molecules, such as PARP, Bax, Bcl-2, Bak and AIF, were assayed by Western blotting analysis with 40¥ìM of HS-1200 combined with 8 Gy irradiation. To examine the cellular location of cytochrome c, bax and AIF immunofluorescent stainings were undertaken

Results: Treatment of MCF-7 cells with 40¥ìM of HS-1200 combined with 8 Gy irradiation showed several changes associated with enhanced apoptosis by agarose gel electrophoresis and Hoechst staining. HS-1200 combined with 8 Gy irradiation treatment also enhanced production of PARP cleavage products and increased Bax/Bcl-2 ratio by Western blotting. Loss of mitochondrial membrane potential (¥Ä¥×m) and increased cytochrome c staining indicated that cytochrome c had been released from the mitochondria in HS-1200 treated cells.

Conclusion: We demonstrated that combination treatment with a synthetic chenodeoxycholic acid derivative HS-1200 and irradiation enhanced radiation-induced apoptosis of human breast cancer cells (MCF-7). We suggest that the increased Bax/Bcl-2 ratio in HS-1200 co-treatment group underlies the increased radiosensitivity of MCF-7 cells. Further futures studies are remained elusive.

Å°¿öµå

ÀÎü À¯¹æ¾Ï ¼¼Æ÷ÁÖ (MCF-7);´ãÁó»ê ÇÕ¼º À¯µµÃ¼(HS-1200);¾ÆÆ÷Åä½Ã½º;¹æ»ç¼± °¨ÀÛ È¿°ú;Synthetic bile acid;HS-1200;Apoptosis;Radiation-induced apoptosis;MCF-7

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS